Dual Antiplatelet Therapy and Cancer; Balancing between Ischemic and Bleeding Risk: A Narrative Review.
acute coronary syndrome (ACS)
atrial fibrillation (AF)
cancer
cardiotoxicity
dual antiplatelet therapy (DAPT)
percutaneous coronary intervention (PCI)
triple antithrombotic therapy (TAT)
Journal
Journal of cardiovascular development and disease
ISSN: 2308-3425
Titre abrégé: J Cardiovasc Dev Dis
Pays: Switzerland
ID NLM: 101651414
Informations de publication
Date de publication:
23 Mar 2023
23 Mar 2023
Historique:
received:
21
01
2023
revised:
15
03
2023
accepted:
19
03
2023
medline:
27
4
2023
pubmed:
27
4
2023
entrez:
27
4
2023
Statut:
epublish
Résumé
Cardiovascular (CV) events in patients with cancer can be caused by concomitant CV risk factors, cancer itself, and anticancer therapy. Since malignancy can dysregulate the hemostatic system, predisposing cancer patients to both thrombosis and hemorrhage, the administration of dual antiplatelet therapy (DAPT) to patients with cancer who suffer from acute coronary syndrome (ACS) or undergo percutaneous coronary intervention (PCI) is a clinical challenge to cardiologists. Apart from PCI and ACS, other structural interventions, such as TAVR, PFO-ASD closure, and LAA occlusion, and non-cardiac diseases, such as PAD and CVAs, may require DAPT. The aim of the present review is to review the current literature on the optimal antiplatelet therapy and duration of DAPT for oncologic patients, in order to reduce both the ischemic and bleeding risk in this high-risk population.
Identifiants
pubmed: 37103014
pii: jcdd10040135
doi: 10.3390/jcdd10040135
pmc: PMC10144375
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Mayo Clin Proc. 2020 Sep;95(9):1865-1876
pubmed: 32861331
J Am Heart Assoc. 2020 Aug 18;9(16):e017212
pubmed: 32805186
Catheter Cardiovasc Interv. 2020 Aug;96(2):E177-E186
pubmed: 31609071
Clin Rev Allergy Immunol. 2022 Jun;62(3):476-483
pubmed: 34129170
Circulation. 2015 Mar 10;131(10):927-64
pubmed: 25679302
Lancet. 2019 Oct 12;394(10206):1300-1302
pubmed: 31492502
N Engl J Med. 2019 Apr 18;380(16):1509-1524
pubmed: 30883055
Ann Palliat Med. 2018 Apr;7(2):265-273
pubmed: 29307210
J Am Coll Cardiol. 2019 Jul 9;74(1):83-99
pubmed: 31272556
Best Pract Res Clin Haematol. 2009 Mar;22(1):9-23
pubmed: 19285269
Herz. 2011 Jun;36(4):348-51
pubmed: 21584715
Eur Heart J. 2018 Mar 1;39(9):763-816
pubmed: 28886620
Am J Cardiovasc Drugs. 2023 Jan;23(1):35-46
pubmed: 36536171
Eur Heart J Acute Cardiovasc Care. 2018 Oct;7(7):639-645
pubmed: 28927294
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
JACC Cardiovasc Interv. 2023 Jan 9;16(1):79-91
pubmed: 36599591
Coron Artery Dis. 2021 Jun 1;32(4):295-301
pubmed: 33196581
J Pers Med. 2022 Aug 25;12(9):
pubmed: 36143156
J Clin Oncol. 2021 Nov 1;39(31):3453-3462
pubmed: 34464154
Stroke. 2021 Jun;52(6):e217-e223
pubmed: 33902301
Eur Heart J. 2021 Mar 7;42(10):1035-1037
pubmed: 33681982
J Natl Cancer Inst. 2011 Sep 7;103(17):1299-309
pubmed: 21743022
Am J Cardiol. 2020 Nov 1;134:83-90
pubmed: 32892987
Heart Views. 2021 Apr-Jun;22(2):127-133
pubmed: 34584624
J Thromb Haemost. 2021 Aug;19(8):1852-1863
pubmed: 33928747
JAMA Cardiol. 2020 May 1;5(5):582-589
pubmed: 32101251
J Oncol Pract. 2018 Feb;14(2):129-133
pubmed: 29182492
Eur Heart J. 2021 Mar 7;42(10):1019-1034
pubmed: 33681960
Eur Heart J. 2018 May 14;39(19):1726-1735a
pubmed: 29668889
Eur Heart J. 2019 Oct 7;40(38):3182-3195
pubmed: 30358849
Circulation. 2021 Oct 19;144(16):1295-1307
pubmed: 34459214
Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719891688
pubmed: 31814532
Expert Rev Cardiovasc Ther. 2020 May;18(5):261-267
pubmed: 32321328
Oncoimmunology. 2014 Feb 14;3:e27987
pubmed: 25340003
J Clin Med. 2022 Mar 24;11(7):
pubmed: 35407399
Pol Arch Intern Med. 2018 Apr 30;128(4):244-253
pubmed: 29708956
Circulation. 2016 Mar 15;133(11):1104-14
pubmed: 26976915
JAMA Cardiol. 2019 Aug 1;4(8):747-755
pubmed: 31215979
N Engl J Med. 2016 Dec 22;375(25):2423-2434
pubmed: 27959713
Europace. 2020 Jul 1;22(7):1036-1043
pubmed: 32464648
Catheter Cardiovasc Interv. 2019 Sep 1;94(3):438-445
pubmed: 30549397
Turk Gogus Kalp Damar Cerrahisi Derg. 2021 Jan 13;29(1):45-51
pubmed: 33768980
Lancet. 2019 Oct 12;394(10206):1335-1343
pubmed: 31492505
Life (Basel). 2023 Feb 28;13(3):
pubmed: 36983821
Catheter Cardiovasc Interv. 2019 Jul 1;94(1):29-37
pubmed: 31104355
Front Cardiovasc Med. 2022 Oct 19;9:901431
pubmed: 36337872
J Cardiovasc Med (Hagerstown). 2020 Dec;21(12):944-952
pubmed: 32520859
J Stroke. 2020 Jan;22(1):1-10
pubmed: 32027788
Eur J Cardiothorac Surg. 2018 Jan 1;53(1):34-78
pubmed: 29045581
Front Cardiovasc Med. 2021 May 21;8:669288
pubmed: 34095258
Eur Heart J. 2017 Dec 14;38(47):3488-3492
pubmed: 29020292
Nat Commun. 2019 Nov 15;10(1):5172
pubmed: 31729378
J Am Coll Cardiol. 2018 May 22;71(20):2335-2342
pubmed: 29544871
Am Heart J. 2017 Dec;194:83-91
pubmed: 29223438
Med Hypotheses. 2021 Jan;146:110442
pubmed: 33303305
Front Cardiovasc Med. 2021 Jun 09;8:590016
pubmed: 34179121
J Am Coll Cardiol. 2022 Jan 18;79(2):197-215
pubmed: 34895951
Curr Pharm Des. 2020;26(23):2789-2803
pubmed: 32282297
N Engl J Med. 2019 May 2;380(18):1706-1715
pubmed: 30883053
Eur Heart J. 2021 Apr 7;42(14):1289-1367
pubmed: 32860058
N Engl J Med. 2017 Sep 14;377(11):1011-1021
pubmed: 28902593
J Invasive Cardiol. 2014 Feb;26(2):E18-20
pubmed: 24486672
Heart. 2005 Apr;91(4):444-8
pubmed: 15772193
JACC CardioOncol. 2019 Dec 17;1(2):145-155
pubmed: 34396175
Semin Neurol. 2018 Apr;38(2):208-211
pubmed: 29791947
JACC Cardiovasc Interv. 2019 Aug 26;12(16):1521-1537
pubmed: 31202949
JACC Cardiovasc Interv. 2019 Jun 10;12(11):1044-1052
pubmed: 31171280
Blood Adv. 2020 Jun 23;4(12):2723-2735
pubmed: 32559295
Eur Stroke J. 2021 Jun;6(2):CLXIII-CLXXXVI
pubmed: 34414299
Curr Opin Hematol. 2014 Sep;21(5):423-9
pubmed: 25054907
Platelets. 2019;30(6):737-742
pubmed: 30252557
Cancer Treat Rev. 2013 Dec;39(8):974-84
pubmed: 23582737
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1291-1305
pubmed: 33567864
N Engl J Med. 2017 Oct 19;377(16):1513-1524
pubmed: 28844193
J Thromb Haemost. 2013 Feb;11(2):223-33
pubmed: 23279708
Cancer Med. 2013 Aug;2(4):564-70
pubmed: 24156029
JACC Cardiovasc Interv. 2021 May 24;14(10):1094-1105
pubmed: 34016406
J Clin Med. 2020 Dec 03;9(12):
pubmed: 33287336
J Clin Oncol. 2019 Aug 1;37(22):1946-1955
pubmed: 31188726
Eur J Cardiothorac Surg. 2018 Jan 1;53(1):5-33
pubmed: 29029110
Hematology. 2005 Jun;10(3):167-75
pubmed: 16019465
Curr Pharm Des. 2020;26(23):2769-2779
pubmed: 32338207
Med J Aust. 2019 Sep;211(6):255-257.e1
pubmed: 31441056
Hellenic J Cardiol. 2023 Feb 1;:
pubmed: 36736730
JACC Cardiovasc Interv. 2021 Aug 9;14(15):1688-1703
pubmed: 34353601
Oncologist. 2017 Oct;22(10):1222-1231
pubmed: 28550032
Expert Opin Drug Saf. 2015 Aug;14(8):1227-36
pubmed: 26059964
J Am Heart Assoc. 2021 Sep 21;10(18):e021686
pubmed: 34482706
Eur J Heart Fail. 2019 Dec;21(12):1515-1525
pubmed: 31321851
Vasc Health Risk Manag. 2018 May 30;14:109-118
pubmed: 29881284
Expert Rev Cardiovasc Ther. 2018 Sep;16(9):675-678
pubmed: 30095350
Eur Heart J Acute Cardiovasc Care. 2021 Oct 27;10(8):947-959
pubmed: 34453829
J Clin Diagn Res. 2017 Jun;11(6):OD05-OD07
pubmed: 28764226
Circulation. 2020 Dec 15;142(24):2299-2311
pubmed: 33003973
Am J Hematol. 2019 Aug;94(8):891-901
pubmed: 31119762
Thromb Res. 2014 May;133 Suppl 2:S49-55
pubmed: 24862146
PLoS One. 2013 Jun 20;8(6):e66721
pubmed: 23818962
Eur Heart J. 2022 Nov 1;43(41):4229-4361
pubmed: 36017568
Cancer Treat Res. 2019;179:191-203
pubmed: 31317489
ESC Heart Fail. 2019 Dec;6(6):1140-1148
pubmed: 31884717
Front Cardiovasc Med. 2021 Aug 04;8:641268
pubmed: 34422918
Hellenic J Cardiol. 2017 May - Jun;58(3):215-219
pubmed: 28258825
BJU Int. 2015 Sep;116(3):358-65
pubmed: 25124891